arcomedlab designs and manufactures customized synthetic bone implants using 3D printing technology with PEEK material, which mimics human bone growth and integrates a gravity-driven drug delivery system. This approach addresses the need for personalized craniofacial implants that enhance healing and aesthetic outcomes while minimizing complications during and after surgery.
Funding
$500K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Reconstruction of craniofacial defects often requires multiple surgeries and may result in imperfect aesthetic and functional outcomes due to limitations in traditional implant design and manufacturing techniques. Current implant solutions may not fully integrate with surrounding tissues, potentially leading to complications and hindering the natural bone regeneration process. Furthermore, localized drug delivery to promote healing and prevent infection is challenging to achieve with conventional implant technologies.
Solution
Arcomedlab provides patient-specific craniofacial implants using advanced 3D printing of PEEK (polyether ether ketone), a biocompatible material with mechanical properties similar to natural bone. Their technology enables the creation of implants with complex geometries and porous structures that mimic human bone, promoting osseointegration and soft tissue interaction. The implants incorporate a unique, gravity-driven drug delivery system, allowing for controlled release of medication directly at the surgical site. This approach facilitates enhanced healing, reduces the risk of complications, and improves overall aesthetic and functional results for patients requiring craniofacial reconstruction.
Target Audience
Arcomedlab's primary customers are surgeons specializing in craniofacial reconstruction, including those in hospitals and specialized clinics focused on plastic surgery, neurosurgery, and oncology.
Features
- Customized implant design based on patient-specific CT scan data
- 3D printing using PEEK material for biocompatibility and bone-like mechanical properties
- Porous implant structure to promote osseointegration and tissue ingrowth
- Integrated, non-electric gravity-driven drug delivery system for localized medication release
- Customizable drug delivery, allowing for tailored treatment regimens
- Controlled drug release for up to 20 days post-surgery
- Manufacturing in a clean room environment to ensure implant sterility and quality
- Compatibility with radiographic examinations and irradiation for cancer patients